Litcius/Paper detail

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

Gary Herman, Meagan P. O’Brien, Eduardo Forleo‐Neto, Neena Sarkar, Flonza Isa, Peijie Hou, Kuo‐Chen Chan, Katharine J. Bar, Ruanne V. Barnabas, Dan H. Barouch, Myron S. Cohen, Christopher B. Hurt, Dale R. Burwen, Mary Marovich, Bret J. Musser, John D. Davis, K. C. Turner, Adnan Mahmood, Andrea T. Hooper, Jennifer D. Hamilton, Janie Parrino, Danise Subramaniam, Alina Baum, Christos A. Kyratsous, A. Thomas DiCioccio, Neil Stahl, Ned Braunstein, George D. Yancopoulos, David M. Weinreich, Achint Chani, Adebiyi Adepoju, Adnan Mahmood, Aisha Mortagy, Ajla Dupljak, Alina Baum, Alison Brown, Amy Froment, Andrea T. Hooper, Andrea Margiotta, Andrew Bombardier, Anita Islam, Anne K. Smith, Arvinder Dhillon, Audra McMillian, Aurora Breazna, Ayesha Aslam, Barabara Carpentino, Bari Kowal, Barry Siliverstein, Benjamin Horel, Bo Zhu, Bret J. Musser, Brian Bush, Brian Head, Brian Snow, Bryan Zhu, Camille Debray, Careta Phillips, Carmella Simiele, Carol Lee, Carolyn Nienstedt, Caryn F. Trbovic, Casey K. Chan, Catherine Elliott, Chad Fish, Charlie Ni, Christa Polidori, Christine Enciso, Christopher Caira, Christopher F. Powell, Christos A. Kyratsous, Cliff Baum, Colin McDonald, Cynthia Leigh, Cynthia X. Pan, Dana Wolken, Danielle Manganello, David Liu, David Stein, David M. Weinreich, Dawlat Hassan, Daya Gulabani, Deborah Fix, Deborah A. Leonard, Deepshree Sarda, Denise Bonhomme, Denise Kennedy, Devin Darcy, Dhanalakshmi Barron, Diana Hughes, Diana Rofail, Dipinder Kaur, Divya Ramesh, Dona Bianco, Donna Cohen, Eduardo Forleo‐Neto, Edward Jean-Baptiste, Ehsan Bukhari, Eileen Doyle, Elizabeth Bucknam

2022The Lancet Infectious Diseases41 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePlaceboVaccinationRandomized controlled trialClinical trialAdverse effectCoronavirus disease 2019 (COVID-19)Vaccine efficacyClinical endpointInternal medicinePediatricsImmunologyDiseasePathologyAlternative medicineInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial | Litcius